TNDM
Tandem Diabetes Care Inc
NASDAQ: TNDM · HEALTHCARE · MEDICAL DEVICES
$18.16
-2.52% today
Updated 2026-04-29
Market cap
$1.24B
P/E ratio
—
P/S ratio
1.23x
EPS (TTM)
$-3.04
Dividend yield
—
52W range
$10 – $30
Volume
2.3M
Tandem Diabetes Care Inc (TNDM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $2.47M | $29.01M | $49.72M | $72.85M | $84.25M | $107.60M | $183.87M | $362.31M | $498.83M | $702.80M | $801.22M | $747.72M | $940.20M | $1.01B |
| Revenue growth (YoY) | — | — | +1072.1% | +71.4% | +46.5% | +15.6% | +27.7% | +70.9% | +97.0% | +37.7% | +40.9% | +14.0% | -6.7% | +25.7% | +7.9% |
| Cost of revenue | — | $3.82M | $22.84M | $34.47M | $46.27M | $60.66M | $63.51M | $94.04M | $168.09M | $238.31M | $326.58M | $388.23M | $380.03M | $450.63M | $483.89M |
| Gross profit | — | $-1.35M | $6.17M | $15.25M | $26.58M | $23.59M | $44.09M | $89.82M | $194.21M | $260.52M | $376.21M | $412.99M | $367.69M | $489.57M | $530.85M |
| Gross margin | — | -54.5% | 21.3% | 30.7% | 36.5% | 28.0% | 41.0% | 48.9% | 53.6% | 52.2% | 53.5% | 51.5% | 49.2% | 52.1% | 52.3% |
| R&D | $8.26M | $9.01M | $11.08M | $15.79M | $16.96M | $18.81M | $20.66M | $29.23M | $45.20M | $63.57M | $92.05M | $170.15M | $248.42M | $198.88M | $174.84M |
| SG&A | $22.93M | $22.62M | $43.82M | $75.12M | $78.62M | $82.83M | $86.38M | $105.23M | $165.74M | $204.90M | $261.51M | $335.68M | $352.50M | $389.82M | $444.99M |
| Operating income | $-24.21M | $-33.05M | $-49.43M | $-75.66M | $-69.00M | $-78.05M | $-62.94M | $-44.63M | $-16.72M | $-7.96M | $22.65M | $-92.85M | $-233.23M | $-99.13M | $-78.12M |
| Operating margin | — | -1335.4% | -170.4% | -152.2% | -94.7% | -92.6% | -58.5% | -24.3% | -4.6% | -1.6% | 3.2% | -11.6% | -31.2% | -10.5% | -7.7% |
| EBITDA | $-22.92M | $-28.46M | $-55.26M | $-71.28M | $-64.17M | $-72.56M | $-56.08M | $-38.81M | $-10.65M | $2.49M | $34.06M | $-74.21M | $-196.46M | $-99.13M | $-174.70M |
| EBITDA margin | — | -1149.9% | -190.5% | -143.3% | -88.1% | -86.1% | -52.1% | -21.1% | -2.9% | 0.5% | 4.8% | -9.3% | -26.3% | -10.5% | -17.2% |
| EBIT | $-24.20M | $-30.49M | $-58.43M | $-75.66M | $-69.00M | $-78.05M | $-62.94M | $-44.63M | $-16.72M | $-7.96M | $20.21M | $-88.54M | $-212.18M | $-99.28M | $-192.37M |
| Interest expense | $542175.00 | $2.53M | $4.71M | $3.90M | $3.74M | $5.71M | $11.34M | $7.58M | $78000.00 | $12.15M | $6.04M | $6.21M | $9.88M | $7.42M | $7.91M |
| Income tax | $542175.00 | $2.53M | $4.71M | $71000.00 | $10000.00 | $-15000.00 | $8000.00 | $51000.00 | $149000.00 | $-1.90M | $335000.00 | $1.74M | $2.36M | $4.16M | — |
| Effective tax rate | -2.2% | -8.3% | -8.1% | -0.1% | -0.0% | 0.0% | -0.0% | -0.0% | -0.6% | 5.2% | 2.1% | -1.9% | -1.1% | -4.5% | 0.0% |
| Net income | $-25.51M | $-33.02M | $-63.14M | $-79.52M | $-72.42M | $-83.45M | $-73.03M | $-122.61M | $-24.75M | $-34.38M | $15.57M | $-94.59M | $-222.61M | $-96.03M | $-204.71M |
| Net income growth (YoY) | — | -29.4% | -91.2% | -26.0% | +8.9% | -15.2% | +12.5% | -67.9% | +79.8% | -38.9% | +145.3% | -707.7% | -135.3% | +56.9% | -113.2% |
| Profit margin | — | -1334.1% | -217.7% | -159.9% | -99.4% | -99.0% | -67.9% | -66.7% | -6.8% | -6.9% | 2.2% | -11.8% | -29.8% | -10.2% | -20.2% |